Selective Activation of Cannabinoid CB2 Receptors Suppresses Hyperalgesia Evoked by Intradermal Capsaicin

Journal of Pharmacology and Experimental Therapeutics

Volumn 308, Issue 2, 2004, Pages 446-453

  Hohmann, Andrea G ^a   Farthing, Jesse N ^a   Zvonok, Alexander M ^b   Makriyannis, Alexandros ^b  

^a University of Georgia ^*  (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(2 IODO 5 NITROPHENYL)[1 (1 METHYLPIPERIDIN 2 YLMETHYL) 1H INDOL 3 YL]METHANONE; 3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANALGESIC AGENT; CANNABINOID; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CAPSAICIN; RIMONABANT; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HYPERALGESIA; INTRADERMAL DRUG ADMINISTRATION; MALE; METABOLISM; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; RAT STRAIN; RECEPTOR UPREGULATION;

ANALGESICS; ANIMALS; CANNABINOIDS; CAPSAICIN; DISEASE MODELS, ANIMAL; HYPERALGESIA; INJECTIONS, INTRADERMAL; MALE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2;

EID: 1642498189     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.060079     Document Type: Article

References (40)

1. Baumann TK, Simone DA, Shain CN, and LaMotte RH (1991) Neurogenic hyperalgesia: the search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia. J Neurophysiol 66:212-227.
2. Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrie B, Rinaldi-Carmona M, Calandra B, Le Fur G, and Casellas P (1996) Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur J Biochem 237:704-711.
3. Buckley NE, McCoy KL, Mezey E, Bonner T, Zimmer A, Felder CC, and Glass M (2000) Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor. Eur J Pharmacol 396:141-149.
4. Chaplan SR, Bach FW, Pogrel JW, Chung JM, and Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55-63.
5. Clayton N, Marshall FH, Bountra C, and O'Shaughnessy CT (2002) CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain 96:253-260.
6. Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL, and Mitchell RL (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443-450.
7. Gilchrist HD, Allard BL, and Simone DA (1996) Enhanced withdrawal responses to heat and mechanical stimuli following intraplantar injection of capsaicin in rats. Pain 67:179-188.
8. Goutopoulos A and Makriyannis A (2002) From cannabis to cannabinergics: new therapeutic opportunities. Pharmacol Ther 95:103-117.
9. Greenhouse SW and Geisser S (1959) On methods in the analysis of profile data. Psychometrika 24:95-112.
10. Hanus L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M, Pertwee RG, Ross RA, Mechoulam R, and Fride E (1999) HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor. Proc Natl Acad Sci USA 96:14228-14233.
11. Hargreaves K, Dubner R, Brown F, Flores C, and Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88.
12. Hohmann AG (2002) Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives. Chem Phys Lipids 121:173-190.
13. Hohmann AG and Herkenham M (1999a) Cannabinoid receptors undergo axonal flow in sensory nerves. Neuroscience 92:1171-1175.
14. Hohmann AG and Herkenham M (1999b) Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience 90:923-931.
15. Ibrahim MM, Deng H, Zvonok A, Cockayne DA, Kwan J, Mata HP, Vanderah TW, Lai J, Porreca F, Makriyannis A, et al. (2003) Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci USA 100:10529-10533.
16. Johanek LM, Heitmiller DR, Turner M, Nader N, Hodges J, and Simone DA (2001) Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms. Pain 93:303-315.
17. Kenins P (1982) Responses of single nerve fibres to capsaicin applied to the skin. Neurosci Lett 29:83-88.
18. Khasabova IA, Simone DA, and Seybold VS (2002) Cannabinoids attenuate depolarization-dependent Ca2+ influx in intermediate-size primary afferent neurons of adult rats. Neuroscience 115:613-625.
19. Konietzny F and Hensel H (1983) The effect of capsaicin on the response characteristic of human C-polymodal nociceptors. J Therm Biol 8:213-215.
20. LaMotte RH, Lundberg LE, and Torebjörk HE (1992) Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol (Lond) 448:749-764.
21. Li J, Daughters RS, Bullis C, Bengiamin R, Stucky MW, Brennan J, and Simone DA (1999) The cannabinoid receptor agonist WIN55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats. Pain 81:25-33.
22. Lynn AB and Herkenham M (1994) Localization of cannabinoid receptors and non-saturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids. J Pharmacol Exp Ther 268:1612-1623.
23. Malan TP Jr, Ibrahim MM, Deng H, Liu Q, Mata HP, Vanderah T, Porreca F, and Makriyannis A (2001) CB2 cannabinoid receptor-mediated peripheral antinociception. Pain 93:239-245.
24. Malan TP, Jr, Ibrahim MM, Vanderah TW, Makriyannis A, and Porreca F (2002) Inhibition of pain responses by activation of CB2 cannabinoid receptors. Chem Phys Lipids 121:191-200.
25. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond) 346:561-564.
26. Mazzari S, Canella R, Petrelli L, Marcolongo G, and Leon A (1996) N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol 300:227-236.
27. Munro S, Thomas KL, and Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature (Lond) 365:61-65.
28. Nackley AG, Makriyannis A, and Hohmann AG (2003a) Inflammation-evoked neurenal activity and pain behavior are attenuated by a peripheral cannabinoid CB2 mechanism. Soc Neurosci Abstr 909.903.
29. Nackley AG, Makriyannis A, and Hohmann AG (2003b) Selective activation of cannabinoid CB2 receptors suppresses spinal Fos protein expression and pain behavior in a rat model of inflammation. Neuroscience 119:747-757.
30. Nackley AG, Suplita RL, 2nd, and Hohmann AG (2003c) A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience 117:659-670.
31. Price TJ, Helesic G, Parghi D, Hargreaves KM, and Flores CM (2003) The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat. Neuroscience 120:155-162.
32. Quartilho A, Mata HP, Ibrahim MM, Vanderah TW, Porreca F, Makriyannis A, and Malan TP Jr (2003) Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology 99:955-960.
33. Ross RA, Coutts AA, McFarlane SM, Anavi-Goffer S, Irving AJ, Pertwee RG, MacEwan DJ, and Scott RH (2001) Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology 40:221-232.
34. Simone DA, Ngeow JY, Putterman GJ, and LaMotte RH (1987) Hyperalgesia to heat after intradermal injection of capsaicin. Brain Res 418:201-203.
35. Sokal DM, Elmes SJR, Kendall DA, and Chapman V (2003) Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurons via activation of CB2 receptors in anesthetized rats. Neuropharmacology 45:404-411.
36. Szolesanyi J, Anton F, Reeh PW, and Handwerker HO (1988) Selective excitation by capsaicin of mechano-heat sensitive nociceptors in rat skin. Brain Res 446:262-268.
37. Torebjork HE, Lundberg LE, and LaMotte RH (1992) Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol (Lond) 448:765-780.
38. Zhang J, Hoffert C, Vu HK, Groblewski T, Ahmad S, and O'Donnell D (2003) Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur J Neurosci 17:2750-2754.
39. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, and Bonner TI (1999) Increased mortality, hypoactivity and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96:5780-5785.
40. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.